<i>Bcl6</i>, <i>Irf2</i>, and <i>Notch2</i> promote nonclassical monocyte development.

O'Connor, Kevin W; Liu, Tiantian; Kim, Sunkyung; Briseño, Carlos G; Georgopoulos, Katia; Murphy, Theresa L; Murphy, Kenneth M · Proc Natl Acad Sci U S A · 2023

basic_science · Level V

Where this comes from

Abstract

Ly6C<sup>lo</sup> monocytes are a myeloid subset that specializes in the surveillance of vascular endothelium. Ly6C<sup>lo</sup> monocytes have been shown to derive from Ly6C<sup>hi</sup> monocytes. NOTCH2 signaling has been implicated as a trigger for Ly6C<sup>lo</sup> monocyte development, but the basis for this effect is unclear. Here, we examined the impact of NOTCH2 signaling of myeloid progenitors on the development of Ly6C<sup>lo</sup> monocytes in vitro. NOTCH2 signaling induced by delta-like ligand 1 (DLL1) efficiently induced the transition of Ly6C<sup>hi</sup> TREML4<sup>-</sup> monocytes into Ly6C<sup>lo</sup> TREML4<sup>+</sup> monocytes. We further identified two additional transcriptional requirements for development of Ly6C<sup>lo</sup> monocytes. Deletion of BCL6 from myeloid progenitors abrogated development of Ly6C<sup>lo</sup> monocytes. IRF2 was also required for Ly6C<sup>lo</sup> monocyte development in a cell-intrinsic manner. DLL1-induced in vitro transition into Ly6C<sup>lo</sup> TREML4<sup>+</sup> monocytes required IRF2 but unexpectedly could occur in the absence of NUR77 or BCL6. These results imply a transcriptional hierarchy for these factors in controlling Ly6C<sup>lo</sup> monocyte development.

Medical subject headings